Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer opens $200m R&D site in St Louis

pharmafile | April 21, 2009 | News story | Research and Development |  Pfizer, US 

Related Content

Cell therapy partnership aims to bring liver disease treatment closer to US patients

Resolution Therapeutics has partnered with the Blood Centers of America (BCA) to support community-based delivery …

Coriolis Pharma opens new US headquarter and laboratory

Coriolis Pharma has opened a new US headquarter and laboratory at the Alexandria Center for …

Abselion establishes a US subsidiary in Massachusetts 

Abselion has established a US subsidiary at The Engine in Cambridge, Massachusetts in the US. …

The Gateway to Local Adoption Series

Latest content

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026

Five Facts about NHS and primary care

September 5, 2026

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026

AI in pharma: From lab development to patient impact

September 5, 2026

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026